Regulation of eNOS by substrates, co-factors, and product recycling The availability of substrates, co-factors, and the efficiency of product recycling are critical factors that dictate the outcome of eNOS activation
Over-the-counter supplements operate under different regulatory frameworks with fewer manufacturing requirements and no obligation to prove efficacy in human studies
Reduction of serotonin transporters of patients with chronic fatigue syndrome
DRD2 agonists, among which cabergoline is the most effective and best tolerated, are first-line therapy for prolactinomas as they are effective in controlling clinical symptoms, PRL levels, and tumor volume (3) and are used to a lesser extent in the treatment of ACTH-secreting tumors (4) and NFPAs (5)
The worldwide prevalence of diabetes has continued to increase dramatically instead of the improvement in outcomes for individual patients with diabetes
Clinical research indicates that berberine is a powerful agent for promoting healthy insulin receptor function and signaling, thereby supporting healthy glucose metabolism